Axsome Therapeutics, Inc. Quarterly Cost of Revenue in USD from Q2 2021 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Axsome Therapeutics, Inc. annual/quarterly Cost of Revenue history and growth rate from Q2 2021 to Q3 2022.
  • Axsome Therapeutics, Inc. Cost of Revenue for the quarter ending September 30, 2022 was $1.9M.
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $1.9M Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $1M $0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-09
Q2 2021 $1M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.